Clinical trial
Association of Possible Biomarkers With Disease Activity in Patients Treated With Teriflunomide (Aubagio)
NCT03561402 is registered in ClinicalTrials.gov with McGill University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Association of Possible Biomarkers With Disease Activity in Patients Treated With Teriflunomide (Aubagio)
- Lead sponsor
- McGill University
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 1, 2016
- Completion date
- December 30, 2020
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.